Home
Conditions
Head and Neck Neoplasms

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

3,775 public trials 1,058 recruiting studies

Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Completed

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

NCT03133286

Conditions: Adnexal Diseases, Anus Diseases, Anus Neoplasms, +74 more
Locations: DxTerity Diagnostics Compton, California, United States

21st Century Oncology Bradenton, Florida, United States

21st Century Oncology Fort Myers, Florida, United States

21st Century Oncology Plantation, Florida, United States

View Trial Details

Completed

Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer

NCT02777385

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer

NCT01847326

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +23 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

AIM1: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid

NCT04472026

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +7 more
Locations: University of Florida Gainesville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

NCT02393690

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Hoag Memorial Hospital Newport Beach, California, United States

University of Colorado Hospital Aurora, Colorado, United States

MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States

View Trial Details

Completed

M6620 Plus Standard Treatment in Oesophageal and Other Cancer

NCT03641547

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +15 more
Locations: Velindre Cancer Centre Cardiff, United Kingdom

Beatson Cancer Centre Glasgow, United Kingdom

St James's University Hospital Leeds, United Kingdom

The Christie Manchester, United Kingdom

View Trial Details

Completed

Hearing Impairment of Nasopharyngeal Carcinoma

NCT05330169

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: the First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Completed

Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT01064479

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

MD Anderson Regional Care Center-Katy Houston, Texas, United States

MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States

MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States

View Trial Details

Completed

BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)

NCT04839471

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

China Medical University Hospital Taichung, Taiwan

National Cheng-Kung University Hospital Tainan, Taiwan

Taipei Veterans General Hospital Taipei, Taiwan

View Trial Details

Completed

Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

NCT04435197

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +17 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Head and Neck Neoplasms

Head and Neck Neoplasms trial results

Related conditions